GlycoMimetics to Present at 34th Annual Canaccord Genuity Global Growth Conference

Canaccord Growth Conference 2014

GAITHERSBURG, Md.--()--GlycoMimetics, Inc. (NASDAQ: GLYC) today announced that Rachel King, Chief Executive Officer, will present an overview of the company at the 34th Annual Canaccord Genuity Global Growth Conference on August 14, 2014, at 1:30 p.m. Eastern Time. The Conference will take place on August 13 and August 14, 2014, in Boston.

To access the live webcast and subsequent archived recordings for the presentation, please visit the GlycoMimetics website at www.glycomimetics.com.

About GlycoMimetics, Inc.

GlycoMimetics is a clinical stage biotechnology company focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using its expertise in carbohydrate chemistry and knowledge of carbohydrate biology, GlycoMimetics is developing a pipeline of glycomimetic drug candidates that inhibit disease-related functions of carbohydrates, such as the roles they play in inflammation, cancer and infection.

Contacts

GlycoMimetics, Inc.
Brian Hahn, 240-243-1207
bhahn@glycomimetics.com

Contacts

GlycoMimetics, Inc.
Brian Hahn, 240-243-1207
bhahn@glycomimetics.com